Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.7 (
DNA polymerase
)
17,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sera of 103 carriers of
hepatitis B
surface antigen were assayed for e-antigen and anti-e. Twenty-four were e-antigen-positive, 31 anti-e-positive, and 48 had neither detectable (e-negative). Aminotransferases were elevated in 75% of the e-antigen-positive carriers compared with 25% of e-negative carriers (P less than 0.001) and 13% of anti-e-positive carriers (P less than 0.001). Serum
DNA polymerase
activity was significantly higher in the e-antigen-positive carriers than in carriers without e-antigen. Dane particles were shown in 10 of 12 carriers with e-antigen, compared with one of 12 e-negative carriers (P less than 0.0003) and none of 12 anti-e-positive carriers (P less than 0.00003). These results suggest that ongoing
hepatitis B
viral replication is more active in e-antigen-positive carriers than in carriers without e-antigen, a finding that may help explain the high prevalence of chronic active hepatitis described in these individuals.
...
PMID:"e" Antigen, Dane particles, and serum DNA polymerase activity in HBsAg carriers. 97 Jul 72
Partially purified preparations of e-antigen, obtained from sera of
hepatitis B
antigen carriers, were chromatographed on columns of immobilized single- or double-stranded DNA or on pyran-Sepharose. e-Antigen did not adsorb to any of these columns under conditions appropriate for the retention of various nucleic acid polymerases. Therefore, e-antigen and the
DNA polymerase
associated with Dane particles can be regarded as distinct proteins.
...
PMID:Evidence against the postulated identity of e-antigen with DNA polymerase associated with the hepatitis B candidate virus. 103 Jun 94
Several methods are presented for the purification of core particles of
hepatitis B
virus (HBV) from nuclei of infected human hepatocytes. No endogenous
DNA polymerase
activity was found in any of the preparations of core particles even when circular double and single stranded DNAs were used as exogenous templates. The
DNA polymerase
activity associated with serum HB Ag was not stimulated by circular DNAs. Sodium dodecyl sulfate (SDS) at concentrations of greater than or equal to 0.1% inhibited the
DNA polymerase
activity of serum HB Ag. Exogenous templates such as native and activated calf thymus and Micrococcus lysodeikticus DNAs did not stimulate the
DNA polymerase
of serum HB Ag even in the presence of low concentrations of SDS. It is suggested that the
DNA polymerase
associated the HB Ag is specific for its own DNA as template.
...
PMID:Observations on the core particle of hepatitis B virus and the DNA polymerase associated with hepatitis B antigen. 118 29
The core of the Dane particle was shown to contain a
DNA polymerase
and a circular double stranded DNA with a molecular weight of 1.6 X 10(6) daltons which served as the primer-template for the enzyme. The product of the
DNA polymerase
reaction was in a base paired form and was covalently attached to the circular DNA. Neither the circular DNA nor the attached DNA product of the enzyme reaction was attacked by the DNase or released from intact cores until the cores were disrupted with sodium dodecyl sulfate, suggesting that they are internal components of the core. The
DNA polymerase
is a specific marker for Dane particles and can be used to distinguish sera with high and low concentrations of Dane particles. The
DNA polymerase
reaction can also be used to radiolabel Dane particle cores for a specific and sensitive radioimmunoprecipitation assay for antibody against the
hepatitis B
core antigen (anti-HBc).
...
PMID:DNA and DNA polymerase in the core of the Dane particle of hepatitis B. 118 30
Two different categories of
hepatitis B
antigen carriers have been investigated. One comprises patients treated with dialysis and known to be highly infectious. The other consists of blood donors found in routine screenings. Serum specimens have been studied with regard to Dane particles. Dane-core-associated
DNA polymerase
activity, and e-antigen. The two groups differed markedly in the aspects studied. The five healthy blood donors had no, or very few, detectable Dane particles and no detectable
DNA polymerase
activity; four of the five healthy donors had antibodies against e-antigen. The one xickk donor and all six dialysis patients had many Dane particles and polymerase activity; five of the sick dialysis patients had e-antigen. Thus, these results further underline the difference between the two groups, and e-antigen and
DNA polymerase
activity could represent possible useful parameters for judging infectivity.
...
PMID:Dane particles, DNA polymerase, and e-antigen in two different categories of hepatitis B antigen carriers. 119 24
In acute cases of hepatitis,
DNA polymerase
activity was found 2 to 3 times more frequently than positive radioimmunoassay. For each case the
DNA polymerase
reactivity was shown to be associated with
hepatitis B
antigens. Inhibitors to this
DNA polymerase
, with properties of IgM and IgG antibody, were found in 13 of 34 cases of acute hepatitis but only in 1 case out of 22 of cirrhosis. During the course of the acute disease these antibodies were detected 3 times more frequently than those to HBs antigen; the two types of antibodies were almost always found separately in different patients, those to
DNA polymerase
were apparently transient and developed earlier since they were found as early as 3 days after the clinical onset and no later than the 6th week following the onset.
...
PMID:Comparison of DNA polymerase and radioimmune assays for the detection of hepatitis B antigens and antibodies. 120 57
One of the particulate forms bearing
hepatitis B
antigen in human blood, the 42 nm Dane particle, has been shown to contain a small circular-stranded DNA with a molecular weight round 1.6 X 10(6) daltons and a
DNA polymerase
. The circular DNA functions as a primer-template for the
DNA polymerase
. The circular DNA, the
DNA polymerase
and the DNA product of the enzyme reaction appear to be internal components of the 28 nm core of the Dane particle. Dane particle cores labeled with H3 in a
DNA polymerase
reaction have been used in a sensitive double antibody precipitation assay for the antibody against core.
...
PMID:DNA and DNA polymerase of a virus-like particle in hepatitis B. 120 60
Studies conducted in 1970 and 1971 with heat-inactivated MS-2 serum revealed that this active immunizing procedure was associated with a protective effect, a more attenuated
hepatitis B
infection and a decreased
hepatitis B
carrier rate. More recent studies have revealed striking differences in the response of unimmunized and immunized persons following a parenteral exposure to the MS-2 strain of
hepatitis B
virus. Serial tests for the detection of
hepatitis B
surface antigen (HBsAg),
DNA polymerase
activity, serum transaminase (SGOT), antibody to HBsAg (anti-HBs) and antibody to
hepatitis B
core antigen (anti-HBc) revealed the following findings. In serosusceptible unimmunized persons HBsAg was detectable about 4 weeks after exposure,
DNA polymerase
activity at about 6 weeks, abnormal SGOT levels at about 8 weeks, anti-HBc at about 8-10 weeks, and anti-HBs usually after 20 weeks. In successfully immunized persons HBsAg,
DNA polymerase
activity, abnormal SGOT levels, and anti-HBc were not detectable, evidence of a booster response of pre-existing or non-detectable anti-HBs was observed one to two weeks after exposure. Studies by various investigators have revealed that anti-HBs is associated with protection and resistance to reinfection. In contrast, anti-HBc is not protective and does not correlate positively with either resistance to infection or recovery from infection. The availability of sophisticated biophysical and biochemical techniques has enabled several investigators to prepare candidate inactivated
hepatitis B
vaccines from purified preparations of HBsAg. The successful propagation of hapatitis B virus infection to susceptible chimpanzees has provided an excellent animal model for the evaluation of
hepatitis B
vaccines. At the present time various investigators are studying the immunogenic and protective effect of the vaccine in these animals. Prospects for the development of a vaccine for the prevention of viral hepatitis type B are encouraging. It is extraordinary that this objective will be achieved in spite of the failure to isolate the etiologic agent in tissue culture.
...
PMID:Viral hepatitis type B: propects for active immunization. 120 71
Hepatitis B
core antigen, antibody to core antigen, and
DNA polymerase
activity were measured in sera from a select group of post-transfusion
hepatitis B
patients who had been followed prospectively following blood transfusion. Preliminary results of this study have revealed (1) that RIA testing of blood would not eliminate but would reduce post-transfusion
hepatitis B
infections by about 50 per cent; (2) that infection with HB virus is modified or aborted in the presence of pre-existing antibody to HB surface antigen; and (3) that transfusion of blood containing anti-HBs does not increase the risk of post-transfusion
hepatitis B
. HBc Ag and/or
DNA polymerase
activity were observed in the sera of all recipients tested who developed liver enzyme abnormalities along HBs Ag and anti-HBc.
DNA polymerase
activity usually occurred in the early stages of incubation before the transaminase became abnormal, whereas HBc Ag was more often associated with increasing enzymatic evidence of liver damage, suggesting release of core structures from the hepatocytes. The presence of
DNA polymerase
without detectable HBc Ag may be due to the presence of intact Dane particles in the sera, preventing recognition of the core antigen. No serological evidence of
hepatitis B
was observed in the sera of 24 other recipients who developed abnormal transaminases. Immunoelectron microscopy of these same sera revealed evidence of exposure to hepatitis A antigen following transfusion in at least two recipients.
...
PMID:Hbc ag, anti-HBC, and DNA polymerase activity in transfused recipients followed prospectively. 123 76
The purification is described of liver-derived
hepatitis B
core antigen (HBc Ag) from human hepatocytes demonstrating only intranuclear particles by electron microscopy. The purified preparation contained 5 x 10(11) particles per ml. The particles were mono-dispersed and relatively free of background material. DNA-dependent polymerase activity was present and had greater activity than an equal number of cores derived from Dane particles isolated from plasma. Specificity of the polymerase reaction was confirmed by precipitation of the activity with specific anti-HBc antiserum. A proportion of the liver-derived core particles was nonreactive for
DNA polymerase
activity. The polymerase-positive population of particles had a larger size than the polymerase-negative population of liver-derived cores as evidenced by gel filtration in Sepharose 4B.
...
PMID:Endogenous DNA polymerase-positive core particles from hepatitis-infected hepatocytes. 123 61
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>